Cargando…
Effective treatment of a child with adenoidal hypertrophy and severe asthma by omalizumab: a case report
BACKGROUND: Childhood adenoid hypertrophy (AH) is common and is often associated with allergic asthma, resulting in complications like obstructive sleep apnea syndrome (OSAS). Management of the disease and its complications is often challenging. CASE PRESENTATION: We report here a case of a 10-year-...
Autores principales: | Sui, Haijing, Zhang, Huishan, Ding, Wei, Zhao, Zuotao, Mo, Jiali, Yuan, Jiexin, Ye, Leping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588247/ https://www.ncbi.nlm.nih.gov/pubmed/36274159 http://dx.doi.org/10.1186/s13223-022-00732-9 |
Ejemplares similares
-
Pediatric usage of Omalizumab: A promising one
por: Yu, Lin, et al.
Publicado: (2021) -
Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008) -
Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018) -
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017) -
A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)